Robotic Surgical Procedures Market Rising in United States | Improve the Abilities of Physicians Performing Open Cranial Surgery

 The Robotic Surgical Procedures Market Sizeis projected to grow from USD 4.65 billion in 2020 to USD 19.03 billion in 2027 at a CAGR of 21.8% in the 2020-2027 period. The digital economy affects the world’s trajectory and the societal well-being of common citizens. In addition, it influences everything from resource assignment to income allocation and economic growth. The adoption of the Internet of Things is pushing significant market growth. Additionally, in 5-10 years, the latest technologies such as robotics, AI, and augmented reality can illustrate around 27% of ICT spending. Consumer demand for access to content and products at any time and from any location is propelling the ICT market forward. The ICT sector is lucrative for vendors since it has about 7 billion mobile subscribers and 3 billion Internet, users.

What is Robotic Surgical Procedures?

The Surgical Robots Market report includes in-depth competitive analysis with the aim of estimating financial growth and maximizing profit potential for the business. In the Surgical Robots market research report, industry trends are plotted at macro level which helps clients and businesses to understand the market and possible future issues. The comprehensive data and brilliant forecasting techniques used in this report coincide with precision and accuracy. 

The Surgical Robots Market can be obtained through market details such as growth drivers, latest developments, market business strategies, regional study and future status of the market.The report also covers information including the latest opportunities and challenges in the surgical robot industry, as well as historical and future market trends. The geographic scope of products is also methodically taken into account for major global areas such as Asia, North America, South America and Africa. An international report on Surgical Robots offers suitable solutions to complex business challenges and works towards an effortless decision-making process.

Get a Sample Copy of the Report at – https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100124

The Surgical Robotics Market research report aims at providing a quick overview of the overall performance of the industry and significant novel trends. Important insights, as well as findings, latest key drivers, and constraints, are also depicted here. A huge array of quantitative and qualitative techniques is used by market analysts including in-depth interviews, ethnography, customer surveys, and analysis of secondary data. It becomes easy for major players to collect important data regarding key organizations along with insights such as customer behavior, market size, competition, and market need. By referring to this Surgical Robotics market study report, it becomes easy for key players to take evidence-based decisions.

J&J entered the orthopedic surgical robots market to further intensify the competition

Similarly, competition is expected to get intensified in the orthopedic space where Stryker is the frontrunner. In 2017, Stryker corporation entered the RAS market with the launch of the Mako system for total knee replacements in the US and more than 1,000 systems have been installed till now globally. In 2019, Zimmer Biomet entered the orthopedic robotic surgery market with the launch of its Rosa platform and has gained some traction in this market. The latest entrant is J&J with the approval of its robotic-assisted orthopedic surgical platform for total knee replacements in 2021. The availability of multiple devices will enhance the penetration of bots and hence, is expected to lead to growth in the surgical robots market.

Key players covered in the global Robotic Surgical Procedures Market research report:

  • Intuitive Surgical (Delaware, United States)
  • Stryker (Michigan, United States)
  • Smith & Nephew (London, United Kingdom)
  • ZIMMER BIOMET (Warsaw, United States)
  • Accuray Incorporated (Sunnyvale, U.S.)
  • CMR Surgical Ltd. (Cambridge, United Kingdom)
  • avateramedical GmbH (Jena, Germany)
  • Johnson & Johnson Services, Inc. (New Brunswick, United States)
  • Medtronic (Dublin, Ireland)

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Comments

Post a Comment

Popular posts from this blog

US Market Trends For Computer-Assisted & Robotics-Assisted Surgery

  In the medical industry, adoption of new cutting-edge technology is slow compared to other industries, such as the automotive industry. 1  Computer-assisted and robotic-assisted surgery (CAS and RAS, respectively) have been around for decades, yet a small percentage of procedures performed take advantage of the innovative solutions available on the market today. In coming years, the number of procedures using robotics and surgical navigation is predicted to increase at a double-digit rate year over year to reach over 6 million procedures by 2028. 2  This rise in CAS and RAS can be attributed to the predicted increase in the utilization of navigation systems and robotic devices as more companies launch new or next-generation systems for assisted surgery. Reasons For Slow CAS And RAS Adoption Some argue that using CAS and RAS is not worth the time and monetary investment, as using this technology often increases procedure planning time and reduces the number of procedures...
Read more

Neoadjuvant Nivolumab Plus Chemo Approved in Canada for Treatment of Resectable Non-Small Cell Lung Cancer

  Neoadjuvant Nivolumab Plus Chemo Approved in Canada for Treatment of Resectable Non-Small Cell Lung Cancer   Health Canada approved nivolumab in combination with platinum-doublet chemotherapy for the neoadjuvant treatment of patients with resectable non–small cell lung cancer prior to surgery. Nivolumab (Opdivo) plus platinum-doublet chemotherapy has been approved by Health Canada for the treatment of certain patients with resectable non–small cell lung cancer, according to Bristol Meyers Squibb. The approval was based on results from the phase 3 CheckMate 816 trial (NCT02998528), in which neoadjuvant nivolumab plus chemotherapy resulted in a 37% reduction in risk of disease progression, recurrence, or death vs chemotherapy alone among patients with resectable NSCLC (HR, 0.63; 97.38%, 0.43-0.91;  P  = .005). The median event-free survival (EFS) with nivolumab/chemotherapy was 31.6 months vs 20.8 months with chemotherapy alone. Improvement in the rate of pathologica...
Read more

USA – Overview of Prothrombin Complex Concentrate Industry and Healthcare Statistics in 2022

Image
The global   Prothrombin Complex Concentrate (PCC) market size  was valued at USD 695.3 million in 2019 and is projected to reach USD 1,604.9 million by 2027, exhibiting a CAGR of 10.6 % during the forecast period Abstract Left ventricular assist devices (LVADs) require careful therapeutic anticoagulation with warfarin to prevent pump thrombosis. However, the best method to reverse warfarin for elective LVAD conversion surgery with massive bleeding remains unclear. We report the case of a 39-year-old Japanese man who was administered a four-factor prothrombin complex concentrate (4F-PCC) as warfarin reversal when he underwent conversion surgery from paracorporeal LVAD to implantable LVAD. 4F-PCC with co-administration of vitamin K reduced the international normalized ratio and R time in TEG6s (Haemonetics Corporation, USA) immediately. The effect was prolonged, and good hemostasis was achieved. 4F-PCC with vitamin K provided good hemostasis in our patient; therefore, 4F-PCC co...
Read more